Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Patients With Advanced Non-small Cell Lung Cancer

NCT00723957 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00723957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00723957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Patients With Advanced Non-small Cell Lung Cancer
Lead sponsor
R-Pharm
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
August 31, 2011
Enrollment
260 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

advanced/metastatic non-small cell lung cancer